Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets

Vancouver, Canada, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation psychedelic, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that Charging Robotics Ltd. (“Charging Robotics”), its 51%-owned subsidiary, has launched the next generation of its autonomous vehicle charging platform, designed for robotaxis, autonomous fleets and automated parking facilities.

The platform uses resonant inductive power transfer technology to transfer electricity across an air gap without physical connectors. The system is designed to deliver charging power of up to 10 kW and achieve efficiency of up to 95% under specified operating conditions through the use of proprietary coils, power electronics and control algorithms designed to support charging in environments with limited space and variable vehicle positioning.